Merck’s marketing of Keytruda was more strategic and their marketing more aggressive. The Global Drug sales of Opdivo stood at USD 9,566.59 Million in 2022, while Keytruda was over $20 billion. What happened?
Merck’s marketing of Keytruda was more strategic and their marketing more aggressive. The Global Drug sales of Opdivo stood at USD 9,566.59 Million in 2022, while Keytruda was over $20 billion. What happened?